126 related articles for article (PubMed ID: 3489981)
1. Impaired alpha-interferon production and natural killer activity in blood mononuclear cells in myelodysplastic syndromes.
Okabe M; Minagawa T; Nakane A; Sakurada K; Miyazaki T
Scand J Haematol; 1986 Aug; 37(2):111-7. PubMed ID: 3489981
[TBL] [Abstract][Full Text] [Related]
2. Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-gamma and tumour necrosis factor-alpha in patients with myelodysplastic syndromes.
Ogata K; Tamura H; Yokose N; An E; Dan K; Hamaguchi H; Sakamaki H; Onozawa Y; Clark SC; Nomura T
Br J Haematol; 1995 May; 90(1):15-21. PubMed ID: 7786778
[TBL] [Abstract][Full Text] [Related]
3. Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipients.
Ramsey KM; Djeu JY; Rook AH
Transplantation; 1984 Oct; 38(4):351-6. PubMed ID: 6388061
[TBL] [Abstract][Full Text] [Related]
4. Alpha-interferon in myelodysplasia; clinical observations and effects on NK cells.
Galvani DW; Nethersell AB; Cawley JC
Leuk Res; 1988; 12(3):257-62. PubMed ID: 3163399
[TBL] [Abstract][Full Text] [Related]
5. Natural killer-interferon system in patients with preleukaemic states.
Takagi S; Kitagawa S; Takeda A; Minato N; Takaku F; Miura Y
Br J Haematol; 1984 Sep; 58(1):71-81. PubMed ID: 6466573
[TBL] [Abstract][Full Text] [Related]
6. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.
Mandler RN; Biddison WE; Mandler R; Serrate SA
J Immunol; 1986 Feb; 136(3):934-9. PubMed ID: 2934481
[TBL] [Abstract][Full Text] [Related]
7. Cimetidine enhances interferon induced augmentation of NK cell activity and suppresses interferon production.
Hirai N; Hill NO; Motoo Y; Osther K
Acta Pathol Microbiol Immunol Scand C; 1985 Aug; 93(4):153-9. PubMed ID: 4050442
[TBL] [Abstract][Full Text] [Related]
8. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide.
Munakata T; Semba U; Shibuya Y; Kuwano K; Akagi M; Arai S
J Immunol; 1985 Apr; 134(4):2449-55. PubMed ID: 3919096
[TBL] [Abstract][Full Text] [Related]
9. Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line.
Howell DN; Andreotti PE; Dawson JR; Cresswell P
J Immunol; 1985 Feb; 134(2):971-6. PubMed ID: 3871222
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of lymphocyte lectin-dependent cytotoxicity in myelodysplastic syndromes.
Fontana L; De Sanctis G; De Rossi G; Bottari V; Petti MC; Ensoli F; Pasqualetti D; Mandelli F
Acta Haematol; 1989; 82(1):1-6. PubMed ID: 2505468
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
[TBL] [Abstract][Full Text] [Related]
12. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation of human leukocytes by staphylococcal enterotoxin A: augmentation of natural killer cells and induction of suppressor cells.
Platsoucas CD; Oleszak EL; Good RA
Cell Immunol; 1986 Feb; 97(2):371-85. PubMed ID: 2943428
[TBL] [Abstract][Full Text] [Related]
14. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
[TBL] [Abstract][Full Text] [Related]
15. Defective mitogen-induced cellular cytotoxicity in myelodysplastic syndromes. Recovery after alpha-interferon administration.
Eliopoulos G; Constantopoulou M; Coulocheri S; Vaiopoulos G; Eliopoulos A; Yataganas X
Anticancer Res; 1991; 11(2):685-9. PubMed ID: 2064322
[TBL] [Abstract][Full Text] [Related]
16. The augmentation of human natural killer cell activity by interferon-gamma is not associated with the induction of the interferon-alpha-inducible proteins.
Gustafsson A; Sundström S; Lundgren E
J Immunol; 1986 Jul; 137(1):167-71. PubMed ID: 3086447
[TBL] [Abstract][Full Text] [Related]
17. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K
J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283
[TBL] [Abstract][Full Text] [Related]
18. Decreased natural killer cell activity after prolonged administration of interferon in cancer patients.
Bravo Cuellar A; Martin Ruiz JL; Orbach-Arbouys S
Immunol Lett; 1985; 10(3-4):137-9. PubMed ID: 4044011
[TBL] [Abstract][Full Text] [Related]
19. Modulation of CD3- large granular lymphocyte functions by agonist and antagonists of protein kinase C: effects on NK and lymphokine-activated killer activity and production of IFN-gamma.
Ortaldo JR; Young HA; Varesio L
J Immunol; 1989 Jul; 143(1):366-71. PubMed ID: 2543702
[TBL] [Abstract][Full Text] [Related]
20. Natural killer activity and NK cytotoxic factors in peripheral blood and lymph node cells from non-Hodgkin's lymphoma patients.
Nadkarni JJ; Mehta BA; Koppikar SB; Soman CS; Shrikhande SS; Advani SH
Neoplasma; 1989; 36(6):701-8. PubMed ID: 2615873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
